ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Achilles Therapeutics PLC

Achilles Therapeutics PLC (ACHL)

0.815
0.005
(0.62%)
Closed 29 June 6:00AM
0.815
0.00
(0.00%)
After Hours: 6:00AM

Income Statement

Balance Sheet

Cash Flow

Quarter End Mar 2023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 1.09M
Operating Income -17.46M
Pre Tax Income -17.46M
Net Income -17.51M
Preferred Dividends 0
Basic Earnings Per Share (EPS) 0
EBIT -17.46M
EBITDA -17.46M
Year End 31 December 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 0531k3.13M7.32M6.08M
Operating Income -13.76M-33.2M-61.06M-71.13M-66.78M
Pre Tax Income -13.99M-33.2M-61.06M-71.07M-69.17M
Net Income -13.99M-33.2M-61.1M-71.18M-69.67M
Preferred Dividends 00000
Basic Earnings Per Share (EPS) 00000
EBIT -13.98M-33.2M-61.06M-71.13M-66.78M
EBITDA -13.46M-32.42M-61.06M-59.99M-62.06M